BioCentury
ARTICLE | Financial News

Prothena financial update

February 3, 2014 8:00 AM UTC

Perrigo Co. plc (NASDAQ: PRGO; Tel Aviv:PRGO, Dublin, Ireland) sold 2.8 million Prothena shares at $26, or about $71.9 million, in a secondary offering underwritten by BofA Merrill Lynch and Citigrou...